Nicole Fein, PA
Surgical · New York, NYNPI 1205933645
Payments from drug & device makers
What this record shows
This record is dominated by other: $224,345 of the $225,056 with a category attached, or 99.7%. Smith+Nephew accounts for 99.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $201,279 and has fallen 96.4% since, to $7,314 in 2025. Among surgical clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 14 payments — averaging $16,075 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$224K
- Stryker$299
- Johnson & Johnson$125
- Medical Device Business Services, Inc.$125
- Merit Medical Systems Inc$78
- Molnlycke Health Care US, LLC$21
What the payments were for
- Food & beverage$7110%
- Other$224,345100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 7 | $224,408 |
| Stryker | 3 | $299 |
| Johnson & Johnson | 1 | $125 |
| Medical Device Business Services, Inc. | 1 | $125 |
| Merit Medical Systems Inc | 1 | $78 |
| Molnlycke Health Care US, LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Engage Partial Knee System$224,345
- Velys$375
- MAKO$172
- ATTUNE$125
How this compares
$225,056 in reported general payments places this provider in the 95th percentile of 1,544 surgical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 43 | $160 |
| Diclofenac Sodium | 13 | $154 |
| Oxycodone Hcl | 19 | $108 |
| Amoxicillin | 21 | $56 |
| Clindamycin Hcl | 13 | $48 |
Paid to pharmacies, not to this prescriber.
Other surgical in New York
- Kenneth RuizNew York$93K
- Terry LinNew York$70K
- James DoolittleNew York$46K
- Irina KommNew York$39K
- Catherine ChoyNew York$24K
- Marianne PistilliNew York$21K
- Ami DalalNew York$16K
- Christopher PrezzanoNew York$14K
- Scott SchneiderNew York$11K
- Amy LuckertNew York$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.